Paige Chamberlain
Analyst
Wolfe Research
Equibles does not estimate personal net worth.
About Paige Chamberlain
Paige Chamberlain is recorded as Analyst at Wolfe Research. Paige Chamberlain has spoken on 3 earnings calls across 3 companies, most recently for Guardant Health, Inc. on July 30, 2026. Those appearances were for Guardant Health, Inc. (GH), NeuroPace Inc (NPCE) and iRhythm Holdings, Inc. (IRTC). The companies whose calls Paige Chamberlain spoke on are classified in the Healthcare sector.
Paige Chamberlain on recent calls
“I wanted to ask on the potential impact to volumes for the G360 tissue test after the FDA approval of the liquid test. you know, the thought being that reimbursement of the liquid test under the MCD might give way to a volume acceleration for the tissue test.”
“I'm hoping to get some quantification around, you know, your market expansion effort through Project Care. I see a couple goals you guys have laid out around this initiative.”
“We're curious for an update on the use of the Philippines team. So do you guys have any key accomplishments in 2024 to highlight and maybe what's the roadmap on that team for 2025?”
Affiliation history
-
Wolfe Research
Analyst
Transcript header (unverified)
Current
Company network
NeuroPace Inc
NPCE
Medical Devices · Healthcare
1 appearance
Latest appearance 2025-11-04
View calls and events